DE VITO, ANDREA
 Distribuzione geografica
Continente #
NA - Nord America 999
EU - Europa 249
AS - Asia 36
AF - Africa 5
Continente sconosciuto - Info sul continente non disponibili 4
OC - Oceania 3
SA - Sud America 1
Totale 1.297
Nazione #
US - Stati Uniti d'America 990
IT - Italia 137
UA - Ucraina 33
DE - Germania 23
HK - Hong Kong 13
GB - Regno Unito 11
CA - Canada 9
CN - Cina 6
RO - Romania 6
IE - Irlanda 5
SE - Svezia 5
BE - Belgio 4
FI - Finlandia 4
FR - Francia 4
PH - Filippine 4
A2 - ???statistics.table.value.countryCode.A2??? 3
AU - Australia 3
BG - Bulgaria 3
BD - Bangladesh 2
HU - Ungheria 2
IL - Israele 2
IN - India 2
JP - Giappone 2
LU - Lussemburgo 2
MZ - Mozambico 2
NL - Olanda 2
SG - Singapore 2
TR - Turchia 2
AT - Austria 1
BR - Brasile 1
CI - Costa d'Avorio 1
CZ - Repubblica Ceca 1
EE - Estonia 1
EU - Europa 1
HR - Croazia 1
MK - Macedonia 1
ML - Mali 1
NG - Nigeria 1
PT - Portogallo 1
RS - Serbia 1
SA - Arabia Saudita 1
SK - Slovacchia (Repubblica Slovacca) 1
Totale 1.297
Città #
Chandler 352
New York 181
Princeton 70
Sassari 51
Ashburn 17
Rome 16
Wilmington 16
Alghero 10
Hong Kong 10
Jacksonville 9
Mountain View 8
Toronto 7
Ann Arbor 5
Dublin 5
Turin 5
Washington 5
Andover 4
Brussels 4
Cagliari 4
Falls Church 4
Helsinki 4
San Francisco 4
Commerce 3
Gonnosfanàdiga 3
Horia 3
Manila 3
Agrigento 2
Assemini 2
Beira 2
Budapest 2
Büdelsdorf 2
Edinburgh 2
Frankfurt am Main 2
Jerusalem 2
London 2
Luxembourg 2
Montreal 2
Norwalk 2
Paris 2
Tokyo 2
West Jordan 2
Abidjan 1
Apo 1
Barsinghausen 1
Beijing 1
Belgrade 1
Bologna 1
Bratislava 1
Brno 1
Burgas 1
Capua 1
Chicago 1
Clearwater 1
Dallas 1
Groningen 1
Guangzhou 1
Haikou 1
Hoofddorp 1
Huskvarna 1
Hyderabad 1
Islington 1
Istanbul 1
Lagos 1
Legnano 1
Lisbon 1
Melbourne 1
Nerviano 1
Ningbo 1
Nuremberg 1
Prilep 1
Pune 1
Quartu Sant'Elena 1
Redmond 1
Riyadh 1
Roubaix 1
Saint Louis 1
San Fernando 1
Santa Clara 1
Seattle 1
Selargius 1
Sofia 1
Somerville 1
Stockholm 1
Sydney 1
Tallinn 1
Woodbridge 1
Zagreb 1
Totale 879
Nome #
Epidemiology, Clinical Aspects, Laboratory Diagnosis and Treatment of Rickettsial Diseases in the Mediterranean Area During COVID-19 Pandemic: A Review of the Literature 53
Olfactory and gustatory function impairment in COVID-19 patients: Italian objective multicenter-study 49
Objective evaluation of anosmia and ageusia in COVID-19 patients: Single-center experience on 72 cases 45
The De Ritis ratio as prognostic biomarker of in-hospital mortality in COVID-19 patients 45
Clinical features, laboratory findings and predictors of death in hospitalized patients with COVID-19 in Sardinia, Italy 44
Bone safety of dolutegravir-containing regimens in people living with HIV: Results from a real-world cohort 38
Dalbavancin two dose regimen for the treatment of prosthetic joint infections: new possible options for difficult to treat infectious diseases 37
A case of vasculitis-like skin eruption associated with COVID-19 36
Efficacy and safety of dolutegravir-based regimens in advanced HIV-infected naïve patients: results from a multicenter cohort study 35
Severity of lung involvement on chest x-rays in sars-coronavirus-2 infected patients as a possible tool to predict clinical progression: An observational retrospective analysis of the relationship between radiological, clinical, and laboratory data 33
The diagnostic usefulness of131i-spect/ct at both radioiodine ablation and during long-term follow-up in patients thyroidectomized for differentiated thyroid carcinoma: Analysis of tissue risk factors ascertained at surgery and correlated with metastasis appearance 31
The The PaO2/FiO2 ratio on admission is independently associated with prolonged hospitalization in COVID-19 patients 31
Does Angiotensin II receptor blockers increase the risk of SARS-CoV-2 infection? A real-life experience 30
Editorial - HIV and cancer during COVID-19 pandemic: Sailing through the perfect storm 30
Effectiveness of Vitamin D Supplements among Patients Hospitalized for COVID-19: Results from a Monocentric Matched-Cohort Study 30
Early treatment with low-molecular-weight heparin reduces mortality rate in SARS-CoV-2 patients 26
Correction to: Tocilizumab for patients with COVID-19 pneumonia. The single-arm TOCIVID-19 prospective trial 25
High-risk sexual behavior and HIV/STDs cascade of care in migrants: Results from an Italian dedicated outpatient clinic 25
Durability of Dolutegravir-Based Regimens: A 5-Year Prospective Observational Study 25
Systemic inflammatory markers and psychophysical olfactory scores in coronavirus disease 2019 patients: is there any correlation? 24
Is oral antibiotic therapy as effective as intravenous treatment in bacterial osteomyelitis? A real-life experience 23
Correlations Between Olfactory Psychophysical Scores and SARS-CoV-2 Viral Load in COVID-19 Patients 23
Chronic viral hepatitis in the italian prison setting: Prevalence, outcomes, literature needs and perspectives 23
Coronavirus disease 2019 (COVID-19)–related smell and taste impairment with widespread diffusion of severe acute respiratory syndrome–coronavirus-2 (SARS-CoV-2) Omicron variant 23
HCV spread among female incarcerated population and treatment pathways to viral elimination in Italian prison settings: clinical perspectives and medico legal aspects 22
The role of routine 131I-SPECT/CT use in differentiated thyroid carcinoma (DTC) follow-up 22
Emerging Clinical Features of COVID-19 Related Pancreatitis: Case Reports and Review of the Literature 22
Correlations between IL-6 serum level and olfactory dysfunction severity in COVID-19 patients: a preliminary study 22
How Little Do We Know about HIV and STIs Prevention? Results from a Web-Based Survey among the General Population 20
Early combination treatment with existing HIV antivirals: An effective treatment for COVID-19? 20
Use of bedaquiline in spinal osteomyelitis and soft tissue abscess caused by multidrug-resistant Mycobacterium tuberculosis: A case report 19
Correlations between IL-6 serum level and olfactory dysfunction severity in COVID-19 patients: a preliminary study 19
Safety and efficacy of molnupiravir in SARS-CoV-2-infected patients: A real-life experience 18
Impact of the presence of the infectious disease specialist in addiction services (SerDs) as a point-of-care to meet WHO goal of HCV eradication 18
Efficacy and durability of two- vs. three-drug integrase inhibitor-based regimens in virologically suppressed HIV-infected patients: Data from real-life ODOACRE cohort 17
HIV Infection Indicator Disease-Based Active Case Finding in a University Hospital: Results from the SHOT Project 17
Could Long-Acting Cabotegravir-Rilpivirine Be the Future for All People Living with HIV? Response Based on Genotype Resistance Test from a Multicenter Italian Cohort 16
Reduced risk of death in people with SARS-CoV-2 infection treated with remdesivir: a nested case-control study 15
Has COVID-19 changed the approach to HIV diagnosis?: A multicentric Italian experience 15
Hashimoto's Thyroiditis and Papillary Thyroid Carcinoma: A Follow-Up Study in Patients with Absence of Aggressive Risk Factors at the Surgery of the Primary Tumor 15
Infectious diseases screening approach among refugees: Results from a single-center study 15
Axillary lymph node hypermetabolism (ALNH) related to COVID-19 vaccination in cancer patients undergoing 18F-FDG PET/CT: a single centre study on 500 cases 14
Mood Reactive Disorders among COVID-19 Inpatients: Experience from a Monocentric Cohort 14
Vaccination and Antiviral Treatment Reduce the Time to Negative SARS-CoV-2 Swab: A Real-Life Study 13
Early versus delayed antiretroviral therapy based on genotypic resistance test: Results from a large retrospective cohort study 12
Vaccination and anti-SARS-CoV-2 treatment reduce disease progression: a real-life experience 12
Human urogenital schistosomiasis in West and Sub-Saharan Africa migrants in Sardinia, Italy: A retrospective monocentric study 11
Quick diagnostic approach for HIV/STDs among migrants: results from a monocentric Italian cohort 10
Predictors of Virological Failure Among People Living with HIV Switching from an Effective First-Line Antiretroviral Regimen 10
Viral Hepatitis C New Microelimination Pathways Objective: Psychiatric Communities HCV Free 10
Time spent with HIV-RNA ≤ 200 copies/ml in a cohort of people with HIV during the U=U era 10
New Onset of Smell and Taste Loss Are Common Findings Also in Patients With Symptomatic COVID-19 After Complete Vaccination 10
Is the 4C Score Still a Valid Item to Predict In-Hospital Mortality in People with SARS-CoV-2 Infections in the Omicron Variant Era? 10
A Comparative Follow-Up Study of Patients with Papillary Thyroid Carcinoma Associated or Not with Graves' Disease 9
Circulation of SARS-CoV-2 Among Asylum Seekers: A Real-Life Experience to Address Health Equity in Piacenza, Italy 9
Efficacy and tolerability of dolutegravir/lamivudine versus dolutegravir/rilpivirine in switching from a three-drug regimen based on nonnucleoside reverse transcriptase inhibitors: A retrospective cohort study 9
Predictors of infection, symptoms development, and mortality in people with SARS-CoV-2 living in retirement nursing homes 9
Impact of Early SARS-CoV-2 Antiviral Therapy on Disease Progression 8
Women Living with HIV in Italian Prison Settings: Results from the Gender-Specific ROSE Network 8
Facing HCV as a Major Public Healthcare Threat in Italy: Epidemiology and Micro-Elimination Pathways among Underserved Populations 8
Reply letter - “Safety and efficacy of oral lopinavir/ritonavir in pediatric patients with coronavirus disease: A nationwide comparative analysis” 8
Five Years With Dolutegravir Plus Lamivudine as a Switch Strategy: Much More Than a Positive Finding 8
In Response to Smell and Taste Loss in COVID-19 After Complete Vaccination: Correspondence 8
Sexually Transmitted Infections Prevalence and Cascade of Care among Undocumented Sex Workers: A Twenty-Year-Long Experience 8
SARS-CoV-2 mRNA Vaccine Response in People Living with HIV According to CD4 Count and CD4/CD8 Ratio 7
SARS-CoV-2 Vaccination Among Incarcerated People: A Barrier to Overcome 7
Quick diagnosis, staging, and treatment of HCV infection among people living in prison: Opinion expert panel 6
Risk of COVID-19 in-hospital mortality in people living with HIV compared to general population according to age and CD4 strata: data from the ICONA network 6
Causes of HIV Treatment Interruption during the Last 20 Years: A Multi-Cohort Real-Life Study 6
The current and future off-label uses of dalbavancin: a narrative review 6
Living with HIV and Getting Vaccinated: A Narrative Review 6
What Is the Efficacy of Sotrovimab in Reducing Disease Progression and Death in People with COVID-19 during the Omicron Era? Answers from a Real-Life Study 4
Recovery from olfactory and gustatory dysfunction following COVID-19 acquired during Omicron BA.1 wave in Italy 4
The high burden of pediatric cystic echinococcosis in Kazakhstan: epidemiological and clinical consequences 4
New treatment strategies for HIV-positive cancer patients undergoing anticancer medical treatment: update of the literature 4
Shedding new light on COVID-19 therapeutics during the omicron era: a deeper dive into real-world data 3
Special Issue "Efficacy and Safety of Antiviral Therapy" 3
Resistance in Pseudomonas aeruginosa: A Narrative Review of Antibiogram Interpretation and Emerging Treatments 3
Switching from tenofovir disoproxil fumarate to tenofovir alafenamide or dual therapy-based regimens in HIV-infected individuals with viral load ≤50 copies/mL: does estimated glomerular filtration rate matter? 3
Long-acting combination of cabotegravir plus rilpivirine: A picture of potential eligible and ineligible HIV-positive individuals from the Italian ARCA cohort 3
Incidence and burden of long COVID in Africa: a systematic review and meta-analysis 3
New score to predict COVID-19 progression in vaccine and early treatment era: the COVID-19 Sardinian Progression Score (CSPS) 2
Knowledge of Sexually Transmitted Infections and HIV among People Living with HIV: Should We Be Concerned? 1
Minimal Extrathyroid Extension (mETE) as the Only Risk Factor in Patients with Papillary Thyroid Carcinoma (PC): Its Clinical Impact on Recurrence and Outcome during Long-Term Follow-Up 1
Totale 1.406
Categoria #
all - tutte 9.637
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 9.637


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/20209 0 1 0 0 2 0 1 0 1 0 4 0
2020/2021138 2 3 14 0 9 16 10 23 44 17 0 0
2021/2022181 4 4 5 1 1 4 2 5 8 18 42 87
2022/2023658 45 76 20 98 49 98 25 80 101 15 39 12
2023/2024420 39 28 20 27 196 92 4 7 2 5 0 0
Totale 1.406